Abstract: The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid release of the active substance takes place.
Type:
Grant
Filed:
November 25, 1998
Date of Patent:
November 7, 2000
Assignee:
Roche Diagnostics GmbH
Inventors:
Jorn Mockel, Rolf-Dieter Gabel, Heinrich Woog